News

Video | Q4 FY24 Investor webinar

1 August 2024

Lumos CEO, Doug Ward, Chief Financial Officer, Barrie Lambert, and Senior VP Commercial Operations, Paul Kase present an overview of the Company‘s outstanding FY24 results and recent progress.

Take a look:

Related news

Lumos Diagnostics receives CPT PLA procedure code approval for FebriDx™ in the US

5 December 2024

Nine News Coverage

21 November 2024

Inquire now

We are inviting qualified B2B Service inquiries for those seeking to develop point-of-care reader technology

By entering your email address you are agreeing to our Privacy Policy.

Innovation at the point-of-care

2024 Lumos Diagnostics